COVID-19 Vaccine Update : India’s COVAXIN Successfully Completes a Phase of Human Clinical Trials – Report!
Home > News Shots > India news The Indian vaccine which was developed indigenously by Bharat Biotech in collaboration with ICMR and Zydus Cadila Ltd, has completed the phase 1 of human clinical trials of COVID-19. It has now moved to phase 2 of clinical trials.
This announcement was made by ICMR's Director-General Blaram Bhargava. He further said that the primary focus once the vaccine completes trials successfully will be to distribute it fairly. "At the present moment, there are three vaccines which are in different phases of clinical testing in India. The first one is the inactivated virus vaccine developed by Bharat Biotech which has completed its Phase 1 study in 11 sites and has started its Phase 2 study. Phase 1 and 2 are safety and very early efficacy studies."
"Similarly Zydus Cadila's DNA vaccine has also completed Phase 1 studies in 11 sites and started its Phase 2 trials which is also progressing. Recombinant Oxford vaccine to be manufactured by Serum Institute of India, Pune was given approval yesterday for Phase 2 and 3 clinical trials which would start within a week at 17 sites," he said.
Until a safe vaccine is established, he reinforced that safety protocols must be adhered to.
From around 141 vaccine candidates which are being studied from across the globe, around 26 are in clinical trials.
OTHER NEWS SHOTS
RELATED NEWS STORIES
- 35,000 Employees to Lose Jobs: Popular Banking Firm to Speed up Process!
- Anna University to Conduct Final Year Exams Online – Dates, AI Invigilation and Other Important Details
- Pune’s Serum Institute Vaccine Receives DCGI Approval – Largest Trial in India to Start!
- While COVID19 Vaccine Candidates are Racing against Each Other, Scientists find a 'NEW' way to Attack the Virus Immediately! Details
- Will the World Find a ‘Vaccine for COVID-19’? – WHO Responds, Gives a Shocking ‘Warning’!
- District Wise Breakup of COVID-19 Cases In Tamil Nadu As On August 3
- Tech Mahindra Introduces & Plans to Extend Benefits For Employees Amid COVID-19: Read How?
- TN Records 'Highest Ever Rise in Death Toll' Today: Check Positive Cases & Recoveries As On August 3
- Oxford Vaccine gets one step Closer towards Arriving at the Indian Market! Human Vaccine Trial and other Latest Developments
- Researchers find this Vaccine SHOT Effective in Controlling COVID19 Spread! Details about the Vaccine